SYRS Financials

Syros Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$0.00

Market Cap

$5,366

EPS

$-1.75

Income Statement Highlights

Most Recent Quarter: 2023-12-31

Revenue

$9.94M

Gross Profit

Operating Income

Net Income

$-164.57M

EPS (Diluted)

$-5.81

Balance Sheet Highlights

Total Assets

$168.17M

Total Liabilities

Shareholders Equity

Cash & Equivalents

$139.53M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-109.71M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

-22863.0%

Operating Margin

-288.9%

ROE

-7.8%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is SYRS revenue?

SYRS's most recent quarterly revenue was $9.94M. Annual revenue can be calculated by summing the four most recent quarters.

Is SYRS profitable?

SYRS reported a loss of $164.57M in the most recent quarter.

What is SYRS market cap?

SYRS has a market capitalization of $5,366, making it a small-cap stock.

Does SYRS have debt?

View SYRS's balance sheet for debt information.

What is SYRS cash flow?

Cash flow data is available in the full financial statements.